The India biosimilar market was valued at INR 4.37 Billion in 2024, fueled by the increasing burden of chronic diseases. It is projected to grow at a CAGR of 14.20% during 2025-2034, reaching approximately INR 16.49 Billion by 2034, supported by expanding healthcare access and rising biosimilar adoption. https://www.expertmarketresearch.com/reports/india-biosimilar-market